article thumbnail

Stakeholder Mapping for Pharmaceutical Products

Celeritas

Stakeholder Mapping involves identifying professionals in the target therapeutic field who would utilize or influence the utilization of the pharmaceutical product. Contacting stakeholders can be key to knowing where they stand upon the release of the pharmaceutical product. Why is Stakeholder Mapping important?

article thumbnail

TOP 10 CHALLENGES IN PHARMACEUTICAL PRODUCT LIFE CYCLE MANAGEMENT

eMediWrite

Understanding a product’s life cycle can assist a company in determining its position in the market relative to rivals and the success or failure of the product. Pharmaceutical packaging is strictly regulated and has to pay attention to ingredients, product quality, and adverse event labeling. Technology transfer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Role of Blockchain Technology in Pharma Supply Chain Transparency

Pharma Marketing Network

In the pharmaceutical supply chain, blockchain technology has the potential to increase transparency and security, allowing for improved tracking and traceability of pharmaceutical products. Blockchain technology is a distributed ledger system that enables secure and transparent transactions.

Pharma 52
article thumbnail

INTERPHEX 2023 – experience science through commercialisation

European Pharmaceutical Review

From development to distribution, INTERPHEX is the leading global event that takes you through all stages of the pharmaceutical product development lifecycle. Technology Based Networking Events including the New Exhibitor Reception, INNOPHEX Reception, Contract Zone Reception and more.

article thumbnail

Rezvilutamide by Jiangsu Hengrui Medicine for Liver Failure (Hepatic Insufficiency): Likelihood of Approval

Pharmaceutical Technology

Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products. Jiangsu Hengrui has R&D facilities in China, the US, and Japan.

article thumbnail

Rezvilutamide by Jiangsu Hengrui Medicine for Prostate Cancer: Likelihood of Approval

Pharmaceutical Technology

Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products. Jiangsu Hengrui has R&D facilities in China, the US, and Japan.

article thumbnail

Pharma’s climate change vulnerability and opportunity

pharmaphorum

In 2019, the pharmaceutical industry produced 48.55 As a critical industry, any disruption to the production or distribution of pharmaceutical products can have significant cost implications for the industry and health ramifications for the global population”. Vulnerability . Making plans is not enough.